Dr. Daphna Y. Gelblum, MD

  • New York, NY
  • Radiation oncologist
NPI1215917604PAC ID9234200494
Medicare services, 2024
3,924
Medicare patients, 2024
623
Part D claims, 2024
446
Publications
112
Clinical trials
2
Practice address
1275 York Avenue, New York, NY 10065
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Memorial Sloan Kettering Cancer Center

Hospital · New York, New York

See all 13 affiliations

Find Dr. Gelblum's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Daphna Y. Gelblum is a radiation oncologist in New York, New York

Dr. Gelblum practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Gelblum's NPI, 1215917604, was assigned on January 20, 2006. Dr. Gelblum graduated from University of Pittsburgh School of Medicine in 1994. Dr. Gelblum holds New York license 199763.

NPI and contact details
Medicare PAC ID
9234200494
NPI enumeration date
January 20, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
58
Medical school graduation
1994

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Daphna Y. Gelblum practices at Memorial Sloan Kettering Cancer Center in New York, New York

Dr. Gelblum's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Source: Dmand AI Affiliation Data

Dr. Daphna Y. Gelblum is affiliated with 6 sites of care and 7 medical groups

Dr. Gelblum's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Monmouth. Dmand AI also links Dr. Gelblum to 6 more medical groups and 5 group practices and clinics, each named with a free account.

See all 13 affiliations for Dr. Gelblum

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Daphna Y. Gelblum's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gelblum practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Memorial Sloan Kettering Cancer CenterAvailable with a free account
+5 more sites and 6 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Gelblum practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Daphna Y. Gelblum is one of 385 radiation oncologists in New York

Radiation oncology is Dr. Gelblum's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Gelblum is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Gelblum's licenses on file in 4 states: New York, Florida, New Jersey and Connecticut.

Specialties and state licenses

  • Radiation oncology, New YorkPrimaryLicense 199763 · 1995 to 2026 · taxonomy 2085R0001X
  • Florida licenseSince 2023
  • New Jersey license2019 to 2027
  • Connecticut license2017 to 2025

Clinical focus

Dmand AI lists bone cancer radiation, head & neck cancer radiation, lung cancer radiation and uterine cancer radiation among the conditions Dr. Gelblum treats.

Radiation oncologists near Dr. Gelblum

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Daphna Y. Gelblum billed Medicare for 3,924 services in 2024

CMS data shows 3,924 Medicare services from Dr. Gelblum across 17 procedure codes in 2024, for 623 Medicare patients. Medicare paid $285,112 for them.

Medicare services, 20243,924
Medicare patients623
Paid by Medicare$285,112
Procedure codes17

Dr. Gelblum's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Other services
2023: 1,4012024: 1,73924%
Imaging
2023: 1,5412024: 1,5923%
Office and hospital visits
2023: 3832024: 44616%
Surgery
2023: 882024: 14767%

Where Dr. Gelblum's Medicare services took place, 2024

  • In an office3,88499%
  • In a facility401%

Dr. Gelblum compared with the New York median for radiation oncologists, 2024

  • Dr. Gelblum
  • New York median
Medicare services
3,924vs 1,0543.7 times
Medicare patients
623vs 1603.9 times
Part D claims
302vs 368.4 times

Medians across 368 radiation oncologists in New York with Dmand AI profiles that report each measure.

Dr. Gelblum's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Gelblum

Need commercial claims for Dr. Gelblum?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Gelblum and other radiation oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Daphna Y. Gelblum treated 623 Medicare patients in 2024, average age 75

CMS counts 623 Medicare patients who saw Dr. Gelblum in 2024. The largest group is 65 to 74, with 301 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gelblum's median patient age at 71, with 44% women.

Medicare patients, 2024623
Average age75
Average risk score2.17
Also on Medicaid10%

Dr. Gelblum's Medicare patients by age, 2024

Dr. Gelblum's Medicare patients by sex, 2024

  • Women29347%
  • Men33053%

Chronic conditions among Dr. Gelblum's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure74%
  3. Cancer67%
  4. Arthritis41%
  5. Ischemic heart disease34%
  6. Anxiety31%
  7. Diabetes26%
  8. Mood disorders25%

Share of Medicare patients with each condition. A patient can have several.

Dr. Gelblum's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women44%
  • Men55%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Daphna Y. Gelblum wrote 446 Medicare Part D claims in 2024

In 2024, Dr. Gelblum wrote 446 Medicare Part D claims for 140 patients. 86% of them were for generic drugs. CMS names the drug for 302 of them, across 15 drugs with 11 or more claims each, at $5,452 in total drug cost. In 2023, CMS named 312 claims across 15 drugs.

Part D claims, 2024446
Drugs named by CMS15
Total drug cost$5,452
Part D patients140

Dr. Gelblum's Part D claims by kind of drug, 2024

  • Generic385 claims86%
  • Brand-name26 claims6%
  • Other35 claims8%

Dr. Gelblum's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Gelblum's Part D claims, 2024

  • Opioids20%90 of 446 claims
  • Antibiotics5%23 of 446 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3122024: 3023%

Drugs named by CMS: 15 in 2024, 15 in 2023.

See all prescribing by Dr. Gelblum

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Daphna Y. Gelblum scored 91 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Gelblum for performance year 2024, reported as part of a group. Dr. Gelblum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gelblum as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Gelblum's MIPS scores, performance year 2024

  • 91of 100Final score
  • 93.7of 100Quality
  • 40of 100Improvement Activities
  • 72of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find radiation oncologists like Dr. Gelblum by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Daphna Y. Gelblum has 112 publications on record

Dmand AI links 112 papers to Dr. Gelblum, published from 2010 to 2025. 2023 was the busiest year, with 15. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Chemoradiotherapy. Dr. Gelblum has published most often in Int J Radiat Oncol Biol Phys. Dr. Gelblum's most frequent co-authors are Abraham Jing-Ching Wu, MD, Andreas Rimner, MD and Narek Shaverdian, MD.

Papers112
Years published2010 to 2025

Dr. Gelblum's papers by year, 2016 to 2025

Topics Dr. Gelblum writes about most

  • Lung Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Chemoradiotherapy
  • Head and Neck Neoplasms
  • Radiotherapy Dosage
  • Radiotherapy, Intensity-Modulated
  • Radiosurgery
  • Oropharyngeal Neoplasms

Dr. Gelblum's most frequent co-authors

Recent publications by Dr. Gelblum

See all 112 publications and co-authors

See who Dr. Gelblum researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Gelblum works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Daphna Y. Gelblum has worked on 2 clinical trials

Dmand AI links Dr. Gelblum to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

Clinical trials with Dr. Gelblum by phase

  1. 1Phase 1: 1 trial
  2. 1Phase 2: 1 trial
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Conditions in Dr. Gelblum's trials

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Bronchogenic

Investigators on the most trials with Dr. Gelblum

Recent clinical trials with Dr. Gelblum

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Daphna Y. Gelblum received $1,085 in industry payments from 2017 to 2024

CMS Open Payments shows 8 general payments to Dr. Gelblum from 3 drug and device companies from 2017 to 2024. Travel and lodging make up the largest share, 87% of the total. Merck Sharp & Dohme Corporation paid the most, $1,048.

General payments to Dr. Gelblum by program year, 2017 to 2024

General payments to Dr. Gelblum by kind, 2017 to 2024

$1.1Kin total
  • Travel and lodging$94287%
  • Food and beverage$13212%
  • Education$111%

Companies that paid Dr. Gelblum the most, 2017 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Gelblum

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Daphna Y. Gelblum graduated from University of Pittsburgh School of Medicine

Dr. Gelblum graduated from University of Pittsburgh School of Medicine in 1994. Dr. Gelblum is a member of ASTRO and ASCO.

  1. Medical schoolUniversity of Pittsburgh School of Medicine
  2. Board certified in radiation oncologyAmerican Board of Radiology

Source: Dmand AI Professional Profile Data

Dr. Daphna Y. Gelblum accepts plans from 14 insurance carriers

Dr. Gelblum is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.

  • Aetna
  • Elevance
  • Excellus BlueCross BlueShield
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • Blue Cross Blue Shield of Massachusetts
  • HCSC
  • MVP Health Care
  • +6 more carriersWith a free account

Plan types Dr. Gelblum accepts, by number of carriers

  1. Medicare9
  2. PPO9
  3. POS6
  4. EPO5
  5. HMO5
  6. Medicaid2

Source: Dmand AI Insurance Network Data

Sources for Dr. Daphna Y. Gelblum's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Daphna Y. Gelblum

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Daphna Y. Gelblum's NPI number?

Dr. Daphna Y. Gelblum's NPI number is 1215917604. It was assigned on January 20, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Daphna Y. Gelblum?

Dr. Daphna Y. Gelblum is a radiation oncologist in New York, New York. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Daphna Y. Gelblum practice?

Dr. Gelblum practices at 1275 York Avenue, New York, NY 10065. Dr. Gelblum's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Gelblum to 6 medical groups and 5 group practices and clinics.

What is Dr. Daphna Y. Gelblum's medical license number?

Dr. Gelblum holds New York license 199763, one of the licenses on file in 4 states.

Which states has Dr. Daphna Y. Gelblum been licensed in?

Dmand AI has state licenses on file for Dr. Gelblum in New York (1995 to 2026), Florida (since 2023), New Jersey (2019 to 2027) and Connecticut (2017 to 2025).

Which hospitals is Dr. Daphna Y. Gelblum affiliated with?

Dr. Gelblum practices at Memorial Sloan Kettering Cancer Center in New York, New York.

What medical group is Dr. Daphna Y. Gelblum part of?

Dr. Gelblum is linked to Memorial Sloan Kettering Monmouth. Dmand AI links Dr. Gelblum to 6 more medical groups.

Does Dr. Daphna Y. Gelblum accept Medicare?

Yes. CMS data shows Dr. Gelblum billed Medicare for 3,924 services in 2024, and Dr. Gelblum accepts Medicare assignment.

Does Dr. Daphna Y. Gelblum offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Gelblum as offering telehealth services.

What is Dr. Daphna Y. Gelblum's MIPS score?

Dr. Gelblum's MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Daphna Y. Gelblum see?

CMS counts 623 Medicare patients who saw Dr. Gelblum in 2024, with an average age of 75.

Is Dr. Daphna Y. Gelblum board certified?

Yes. Dr. Gelblum is board certified in radiation oncology by the American Board of Radiology.

What services does Dr. Daphna Y. Gelblum bill to Medicare?

In 2024, Dr. Gelblum's most billed Medicare services were medicare service (G6002), radiation oncology (77300) and radiation oncology (77427).

Where did Dr. Daphna Y. Gelblum go to medical school?

Dr. Gelblum graduated from University of Pittsburgh School of Medicine in 1994.

What drugs does Dr. Daphna Y. Gelblum prescribe most?

In 2024 Medicare Part D data, Dr. Gelblum's most prescribed drugs by claims were Oxycodone HCl, Pentoxifylline and Omeprazole.

Has Dr. Daphna Y. Gelblum received payments from drug or device companies?

CMS Open Payments shows $1,085 in general payments to Dr. Gelblum from 3 companies from 2017 to 2024. The largest total came from Merck Sharp & Dohme Corporation.

How long has Dr. Daphna Y. Gelblum been practicing?

Dr. Gelblum graduated from medical school in 1994, 32 years ago.

Does Dr. Daphna Y. Gelblum do research?

Dmand AI links 112 publications to Dr. Gelblum, published from 2010 to 2025. Dr. Gelblum has worked on 2 clinical trials.

Who does Dr. Daphna Y. Gelblum publish with?

Dr. Gelblum's most frequent co-authors are Abraham Jing-Ching Wu, MD (43 shared papers), Andreas Rimner, MD (39 shared papers) and Narek Shaverdian, MD (33 shared papers).

What insurance does Dr. Daphna Y. Gelblum accept?

Dr. Gelblum is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to radiation oncology practices?

See radiation oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)